IP Library Granted Patent US 9,586,008
Granted Patent B2
US 9,586,008 · App. 14/333,465 · Granted Mar 7, 2017

Syringes for sequential delivery of injectables

Inventors: Gautam N. Shetty (Lancaster, PA); Lance W. Wetzel (Spring Grove, PA); Lou Castagna (Middletown, PA)
Assignee: UNITRACT SYRINGE PTY LTD
A61M5/2448A61M5/31525A61M5/31535A61M5/31578A61M5/31591A61M5/31596A61M5/322A61M5/3234A61M2005/2451A61M2005/3128
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,586,008
App. No.
14/333,465
Granted
Mar 7, 2017
Kind
B2
Abstract

Sequential delivery syringes including a valve mechanism are configured and configurable to enable one or more substances to be prefilled into the syringe. The valve mechanism may be an aspect of a distal seal assembly. Actuation of the valve mechanism permits opening of a fluid passage for the mixing of one or more substances, and the resulting mixed substance can be delivered by the syringe, for example, for administration of a pharmaceutical to a subject. The sequential delivery of substances contained in a distal and proximal chamber is also provided, where a second substance from the distal chamber is delivered followed by the delivery of a first substance from the distal chamber after the first substance from the proximal chamber is transferred into the distal chamber involving the actuation of the valve mechanism.

Claims (36)

1. A prefillable sequential delivery syringe comprising

a syringe housing;

a distal seal assembly axially displaceably disposed within the housing, wherein the position of the distal seal assembly defines a mutable distal chamber and a mutable proximal chamber within the housing;

the distal seal assembly further comprising a valve that regulates a fluid passage between the proximal and distal chambers;

a proximal seal;

a connector configured to connect irreversibly the proximal seal and the distal seal assembly, wherein the connected proximal seal and distal seal assembly translate axially together within the housing; and

a plunger rod positioned coaxially within the syringe housing and engaged with the distal seal assembly, wherein the plunger rod is configured to releasably engage a locking mechanism to actuate the valve.

2. The sequential delivery syringe of claim 1 , wherein the syringe further comprises an insert housed at least partially within the distal seal assembly, wherein the insert comprises an internal cavity configured to engage a distal end of the plunger rod.

3. The sequential delivery syringe of claim 2 , wherein the insert comprises at least one channel or compartment that regulates movement of the plunger rod within the insert, and wherein the insert comprises at least one fluid passage.

4. The sequential delivery syringe of claim 2 , wherein the insert comprises at least one connector to engage with the proximal seal.

5. The sequential delivery syringe of claim 1 , wherein the locking mechanism comprises a radial channel configured to be rotatably engaged by a plunger rod protrusion.

6. The sequential delivery syringe of claim 1 , wherein the distal chamber, proximal chamber, or both, contains a substance.

7. The sequential delivery syringe of claim 6 , wherein the substance comprises a pharmaceutical agent.

8. The sequential delivery syringe of claim 7 , wherein the pharmaceutical agent is selected from the group consisting of a biologic, a vaccine, a chemotherapeutic agent, a contrast agent, a small molecule, an immunogen, an antigen, an interferon, a polyclonal antibody preparation, a monoclonal antibody, an anesthetic, an interfering RNA, a gene vector, an insulin, and a combination of any of these.

9. The sequential delivery syringe of claim 6 , wherein the substance is lyophilized.

10. The sequential delivery syringe of claim 6 , wherein the substance is a diluent.

11. The sequential delivery syringe of claim 1 , wherein the syringe further comprises a dose control mechanism.

12. The sequential delivery syringe claim 1 , wherein the syringe further comprises a luer type connection at a distal end of the syringe housing.

13. The prefillable sequential delivery syringe of claim 1 , wherein the syringe further comprises a retractable needle mechanism at a distal end of the syringe housing.

14. A prefillable sequential delivery syringe comprising

a syringe housing;

a proximal seal assembly axially displaceably disposed within the housing;

a distal seal assembly axially displaceably disposed within the housing, wherein the position of the distal seal assembly defines a mutable distal chamber and a mutable proximal chamber within the housing;

the distal seal assembly further comprising a valve that regulates a fluid passage between the proximal and distal chambers;

a proximal seal;

a connector configured to connect irreversibly the proximal seal and the distal seal assembly, wherein the connected proximal seal and distal seal assembly translate axially together within the housing;

a plunger rod positioned coaxially within the syringe housing and engaged with the valve, wherein the plunger rod actuates the valve; and

a releasable locking mechanism comprising a connection for engaging the proximal seal assembly and the plunger rod to prevent actuation of the valve, and further comprising a release for disengaging the proximal seal assembly from the plunger rod.

15. The sequential delivery syringe of claim 14 , wherein the distal chamber, proximal chamber, or both, contains a substance.

16. The sequential delivery syringe of claim 15 , wherein the substance comprises a pharmaceutical agent.

17. The sequential delivery syringe of claim 16 , wherein the pharmaceutical agent is selected from the group consisting of a biologic, a vaccine, a chemotherapeutic agent, a contrast agent, a small molecule, an immunogen, an antigen, an interferon, a polyclonal antibody preparation, a monoclonal antibody, an anesthetic, an interfering RNA, a gene vector, an insulin, and a combination of any of these.

18. The sequential delivery syringe of claim 15 , wherein the substance is lyophilized.

19. The sequential delivery syringe of claim 15 , wherein the substance is a diluent.

20. The sequential delivery syringe of claim 14 , wherein the syringe further comprises a dose control mechanism.

21. The sequential delivery syringe of claim 14 , wherein the syringe further comprises a luer type connection at a distal end of the syringe housing.

22. The sequential delivery syringe of claim 14 , wherein the syringe further comprises a retractable needle mechanism at a distal end of the syringe housing.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2025
From: UNL HOLDINGS LLC
To: AMGEN INC.
Reel/Frame 073057/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2017
From: UNILIFE CORPORATION; UNILIFE MEDICAL SOLUTIONS, INC.; UNITRACT SYRINGE PTY LTD ACN 101 059 723; UNILIFE MEDICAL SOLUTIONS PTY LIMITED ACN 008 071 403
To: UNL HOLDINGS LLC
Reel/Frame 043482/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2014
From: SHETTY, GAUTAM N.; WETZEL, LANCE W.; CASTAGNA, LOU
To: UNITRACT SYRINGE PTY LTD
Reel/Frame 034224/0555 →
Continuity (3)
Provisional Application 61846940 · Jul 16, 2013
Provisional Application 61941862 · Feb 19, 2014
Related Publication 20150025456A1 · Jan 22, 2015